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C. elegans GLA-3 is a novel component of the MAP kinase
MPK-1 signaling pathway required for germ cell survival
Abstract
During oocyte development in Caenorhabditis elegans, approximately half of all developing germ cells
undergo apoptosis. While this process is evolutionarily conserved from worms to humans, the regulators
of germ cell death are still largely unknown. In a genetic screen for novel genes involved in germline
apoptosis in Caenorhabditis elegans, we identified and cloned gla-3. Loss of gla-3 function results in
increased germline apoptosis and reduced brood size due to defective pachytene exit from meiosis I.
gla-3 encodes a TIS11-like zinc-finger-containing protein that is expressed in the germline, from the L4
larval stage to adulthood. Biochemical evidence and genetic epistasis analysis revealed that GLA-3
participates in the MAPK signaling cascade and directly interacts with the C. elegans MAPK MPK-1, an
essential meiotic regulator. Our results show that GLA-3 is a new component of the MAPK cascade that
controls meiotic progression and apoptosis in the C. elegans germline and functions as a negative
regulator of the MAPK signaling pathway during vulval development and in muscle cells.
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C. elegans GLA-3 is a novel component
of the MAP kinase MPK-1 signaling
pathway required for germ cell survival
Ekaterini A. Kritikou,1,5 Stuart Milstein,3,5 Pierre-Olivier Vidalain,3,6 Guillaume Lettre,1
Erica Bogan,1,2 Kimon Doukoumetzidis,1,2 Phillip Gray,4 Thomas G. Chappell,4 Marc Vidal,3 and
Michael O. Hengartner1,7
1Institute of Molecular Biology, University of Zurich, 8057 Zurich, Switzerland; 2Ph.D. Program in Molecular Life Sciences,
University of Zurich, 8057 Zurich, Switzerland; 3Center for Cancer Systems Biology (CCSB) and Department of Cancer
Biology, Dana Farber Cancer Institute and Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115,
USA; 4Invitrogen Corporation, Carlsbad, California 92008, USA
During oocyte development in Caenorhabditis elegans, approximately half of all developing germ cells
undergo apoptosis. While this process is evolutionarily conserved from worms to humans, the regulators of
germ cell death are still largely unknown. In a genetic screen for novel genes involved in germline apoptosis
in Caenorhabditis elegans, we identified and cloned gla-3. Loss of gla-3 function results in increased germline
apoptosis and reduced brood size due to defective pachytene exit from meiosis I. gla-3 encodes a TIS11-like
zinc-finger-containing protein that is expressed in the germline, from the L4 larval stage to adulthood.
Biochemical evidence and genetic epistasis analysis revealed that GLA-3 participates in the MAPK signaling
cascade and directly interacts with the C. elegans MAPK MPK-1, an essential meiotic regulator. Our results
show that GLA-3 is a new component of the MAPK cascade that controls meiotic progression and apoptosis in
the C. elegans germline and functions as a negative regulator of the MAPK signaling pathway during vulval
development and in muscle cells.
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Supplemental material is available at http://www.genesdev.org.
Received February 24, 2006; revised version accepted June 1, 2006.
Germ stem cells are the precursors to all subsequent
generations in a species, and, therefore, germ cell forma-
tion is tightly monitored to ensure high-fidelity transfer
of the genetic material. Germ cell genome integrity is
monitored at several checkpoints, allowing for DNA re-
pair, cell cycle arrest, and apoptosis when required. In
mammals, inactivation of genes with checkpoint func-
tion frequently results in aberrant cell death and infer-
tility (Lim and Hasty 1996; Bender et al. 2002). Germ cell
development is also characterized by either massive
waves or low but constant levels of apoptosis that are not
caused by genetic defects. For example, >99.9% of oo-
cytes undergo apoptosis in response to hormonal
changes that occur at several stages during the female
life cycle in mammals (Tilly 2001; Kim and Tilly 2004).
Apoptosis is also the fate of ∼50% of germ cells under-
going oogenesis in the gonad of Caenorhabditis elegans
hermaphrodites. (Gumienny et al. 1999). Characteriza-
tion of the pathways that regulate germ cell death will
contribute to our understanding of the cell suicide deci-
sion and might allow for more efficient therapeutic ma-
nipulation of the apoptotic program.
C. elegans is a good model to study the signaling cas-
cades involved in the decision between germ cell sur-
vival and germ cell death (Hengartner 1997; Gumienny
et al. 1999). The adult hermaphrodite gonads consist of
two U-shaped tubes that are connected at a common
uterus. At the distal end of each gonad, mitotic germ
stem cells proliferate in response to the Notch ligand
LAG-2. Cells beyond the influence of LAG-2 enter meio-
sis and progress through the pachytene stage of meiosis I;
this transition requires activation of the RAS/MAPK
(MAP kinase) signaling cascade (Hubbard and Greenstein
2000; Seydoux and Schedl 2001). Following transition
through pachytene, germ cells can either enter diakine-
sis of meiosis I and differentiate into oocytes or under-
go apoptosis. We previously suggested that these cell
deaths are the result of a physiological, homeostatic con-
trol mechanism that limits the number of germ cells
permitted to differentiate into oocytes (Gumienny et al.
1999).
5These authors contributed equally to this work.
6Present address: Laboratoire génomique virale et vaccination, CNRS
UMR1930, Institut Pasteur de Paris, 28 Rue du Docteur Roux, Paris,
75724 Cedex 15, France.
7Corresponding author.
E-MAIL michael.hengartner@molbio.unizh.ch; FAX 41-44-635-6861.
Article is online at http://www.genesdev.org/cgi/doi/10.1101/gad.384506.
GENES & DEVELOPMENT 20:2279–2292 © 2006 by Cold Spring Harbor Laboratory Press ISSN 0890-9369/06; www.genesdev.org 2279
 on October 11, 2006 www.genesdev.orgDownloaded from 
During C. elegans somatic development, apoptosis is
triggered when the pro-apoptotic BH3-domain-contain-
ing protein EGL-1 interacts with the BCL-2 family mem-
ber CED-9 on the surface of mitochondria. Binding of
EGL-1 induces CED-9 to release the sequestered Apaf-1
homolog CED-4, resulting in the formation of a C. ele-
gans apoptosome and activation of the caspase CED-3
(Chen et al. 2000; Yan et al. 2004, 2005; for review, see
Lettre and Hengartner 2006). We previously showed that
germline apoptosis can be induced by both p53-depen-
dent and p53-independent pathways (Lettre et al. 2004).
However, whereas DNA damage-induced germline apo-
ptosis depends on the activation of EGL-1, physiological
germline apoptosis occurs normally in the absence of
EGL-1, indicating that additional regulatory factors are
required to trigger the apoptotic cascade in these cells
(Gumienny et al. 1999; Gartner et al. 2000).
In an attempt to identify genes that regulate physi-
ological germ cell apoptosis, we performed a forward ge-
netic screen to isolate mutants with increased levels of
germline apoptosis. In this paper, we report the cloning
and characterization of gla-3 (germline apoptosis), a gene
that encodes a predicted RNA-binding protein of the
TIS11 family. Loss of gla-3 function results in increased
germ cell apoptosis and severe defects in oocyte differ-
entiation, which lead to reduced brood size. Biochemical
analysis revealed that GLA-3 physically interacts with
the C. elegans MAPK MPK-1, providing a direct link
between the apoptotic process and oogenesis. Further-
more, we show that GLA-3 functions as an inhibitor of
the MAPK cascade during vulva formation and in muscle
cells. Our findings indicate that GLA-3 is a new compo-
nent of the MAPK signaling cascade and highlight a mo-
lecular link between germ cell survival and pachytene
progression in the C. elegans germline.
Results
Loss of gla-3 function results in increased germ cell death
To identify novel genes involved in the regulation of germ-
cell apoptosis, we performed a forward genetic screen to
isolate mutations that result in increased germline apo-
ptosis, as described in Materials and Methods. gla-3 was
selected for cloning and further characterization based
on the severity of its germline apoptosis phenotype. All
three gla-3 alleles that we analyzed (op212 and op216,
isolated in our screen, and ep312, generously provided by
M. Costa, Exelixis) resulted in increased numbers of
germ cell corpses that displayed typical apoptotic mor-
phology (Fig. 1A,B). Because gla-3 mutants exhibited nor-
mal patterns of somatic cell death (data not shown), we
conclude that gla-3 is not a general cell-death regulator.
To investigate whether loss of gla-3 function results in
increased germ cell apoptosis rather than decreased en-
gulfment, we analyzed gla-3 mutants carrying the inte-
grated transgene opIs110, which expresses a YFP-tagged
version of cytosolic actin. We previously showed that
this YFPACT-5 reporter is highly enriched around ap-
optotic germ cells that are in the process of being en-
gulfed (Kinchen et al. 2005). Whereas inactivation of the
engulfment gene ced-1 largely abolished YFPactin
staining, most apoptotic germ cells in gla-3(lf); opIs110
(lf, loss of function) animals were surrounded by a
YFPactin halo, indicating that the cells were being en-
gulfed efficiently (Supplemental Fig. 1). These results
support our notion that loss of gla-3 function results in
increased germ cell death, rather than decreased cell
corpse clearance.
To determine an epistatic relationship between gla-3
and other components of the apoptotic machinery, we
generated strains that contain gla-3(op212) and either of
the strong loss-of-function mutations ced-4(n1162) or
ced-3(n717). In both double mutants, germ cell death
was completely abrogated, demonstrating that gla-3(lf)-
induced cell death is apoptotic in nature and that the
components of the apoptotic machinery function down-
stream of gla-3 (Fig. 1C).
Because germline apoptosis can be mediated by both
DNA damage-dependent and -independent mechanisms
(Gartner et al. 2000), we carried out epistasis analysis
between gla-3(op212) and genes that are known to be
involved in DNA damage responses. hus-1(op244) and
clk-2(mn159ts) mutants are characterized by a complete
absence of DNA damage-induced apoptosis, but have
nearly normal levels of somatic and germline apoptosis
(Ahmed et al. 2001; Hofmann et al. 2002). gla-3(op212);
clk-2(mn159ts) and hus-1(op244) gla-3(op212) worms
had similar levels of germline apoptosis as gla-3(op212)
alone, indicating that gla-3-induced apoptosis occurs in-
dependently of these DNA damage checkpoint genes
(Fig. 1D). Because DNA damage-induced apoptosis is de-
pendent on the p53 homolog cep-1 (Derry et al. 2001;
Schumacher et al. 2001), we inactivated gla-3 using
RNA-mediated interference (RNAi) in cep-1(gk138) mu-
tants. Consistent with our previous findings (Lettre et al.
2004), we observed similar levels of germline apoptosis
in gla-3(RNAi) cep-1(gk138) and in gla-3(RNAi) alone
(Fig. 1E), showing that loss of gla-3 does not activate a
DNA damage apoptotic response.
Finally, we tested the ability of gla-3 mutants to re-
spond to exogenous DNA damage. We previously
showed that ionizing radiation induces apoptosis of mei-
otic cells and transient cell cycle arrest of the mitotic
germ cell population (Gartner et al. 2000). Both apoptosis
and cell cycle responses appeared normal in gla-3(op212)
mutants (Fig. 1D; Supplemental Fig. 2, respectively).
These data suggest that the DNA damage response path-
ways are functional in gla-3 mutants, and are consistent
with a role of gla-3 in the physiological cell-death path-
way.
Identification of mutations in the C. elegans gla-3 gene
We genetically mapped gla-3(op212) to a 0.36-cM inter-
val, on the right arm of Chromosome I, between the
single nucleotide polymorphism markers pk1058 at 2.31
cM and opP106 at 2.67 cM, as described in Materials and
Methods. We inactivated the 40 genes predicted to reside
between these two markers using RNAi, in the hope that
knockdown of the relevant gene would phenocopy gla-
Kritikou et al.
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3(op212). A single gene, T02E1.3, which encodes two
splice variants, gave rise to increased germline apoptosis
when inactivated by RNAi. We sequenced T02E1.3 from
wild-type, op212, and op216 animals and found a C-to-T
transition at position 471 in T02E1.3a (position 574 in
T02E1.3b) in op212, resulting in a premature stop codon
(Fig. 2A), whereas op216 mutants contain a G-to-A tran-
sition in the acceptor splice site of the first intron of
T02E1.3a (Fig. 2A). The third allele of gla-3, ep312, was
generated in an independent screen for mutants with in-
creased germline apoptosis in a cep-1(lf) mutant back-
ground (M. Costa, pers. comm.). ep312 results in a 265-
bp deletion that removes part of the last two exons of
gla-3 and introduces a frameshift at the new junction
(Fig. 2A). Based on the strength of its phenotype and the
molecular nature of the mutation, we believe op212 to
be a null allele of gla-3.
gla-3 encodes a TIS11-like zinc finger domain protein
gla-3 encodes a protein that contains two CCCH-like
zinc-finger domains (Fig. 2B). This domain is found in a
subset of zinc-finger family proteins; its consensus se-
quence corresponds to C-X8–10-C-X5-C-X3-H, where X re-
fers to any amino acid (Varnum et al. 1989). CCCH zinc
fingers were first described in the mouse TIS11 protein,
where they are responsible for nucleic-acid binding (Var-
num et al. 1989; DuBois et al. 1990; Bai and Tolias 1996).
Mammalian TIS11-like zinc-finger-containing proteins
have been shown to function either as transcription fac-
tors or RNA-binding proteins (Taylor et al. 1996; Wor-
thington et al. 2002). Several C. elegans genes encoding
proteins with TIS11-like zinc-finger domains have been
described, including pie-1, mex-1, pos-1, mex-5, and
mex-6, all of which are involved in early blastomere cell-
fate determination and germline development (Mello et
al. 1996; Guedes and Priess 1997; Tabara et al. 1999;
Schubert et al. 2000). In addition, the recently identified
TIS11-like proteins OMA-1, OMA-2, and OMA-3 are re-
dundantly required for prophase progression during oo-
cyte maturation (Detwiler et al. 2001; Shimada et al.
2002). GLA-3 is highly similar to these proteins in the
CCCH zinc-finger domain (Fig. 2B), but bears no signifi-
Figure 1. Loss of gla-3 function results in increased germ cell apoptosis. (A) DIC image of wild-type and gla-3(op212) adult hermaph-
rodite gonads. gla-3(op212) mutants exhibit an increased number of germ cell corpses (arrows). Anterior is to the left and dorsal to the
top. Scale bar, 8 µm. (B) Wild-type and gla-3(lf) mutant worms raised at 25°C were synchronized, and germ cell corpses were counted
starting at the L4 stage. (C) gla-3(op212)-induced germ cell death is abrogated in ced-4(n1162) and ced-3(n717) mutants. (D) Mutations
in DNA damage checkpoint genes do not abrogate gla-3(op212)-induced apoptosis. Synchronized adults (12 h post-L4/adult molt) were
irradiated with 120 Gy, and germ cell corpses were counted 24 h later. The following alleles were used: gla-3(op212), hus-1(op244), and
clk-2(mn159ts). (E) gla-3(RNAi)-induced apoptosis is not blocked in cep-1(gk138) mutants. RNAi-mediated knockdown of the RecA
homolog rad-51, which results in the accumulation of meiotic intermediates and induces CEP-1-dependent apoptosis (Lettre et al.
2004), was used as a positive control. In panels B–E, error bars represent SD from three independent experiments; 20 gonads were scored
in each experiment.
C. elegans GLA-3 controls MAPK signaling
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cant sequence similarity to other characterized proteins
outside of the zinc fingers. Unlike most of the charac-
terized CCCH-zinc-finger-containing proteins in C. el-
egans, the zinc-finger domains in GLA-3 are situated at
the two ends of the protein, ∼400 amino acids apart.
gla-3 is expressed in the germline
We probed a developmental Northern blot from wild-
type animals with a probe hybridizing to both gla-3
transcripts. We found gla-3 to be expressed in embryos,
L4-stage larvae, and adults (Fig. 3A), with the highest
expression being in L4 larvae. The predominant devel-
opmental difference between an L4 larva and an adult
hermaphrodite is the expansion of the germline. To ex-
amine the expression of gla-3 in the adult hermaphrodite
germline, we prepared RNA from three temperature-sen-
sitive mutants, defective in various aspects of germline
development. At the nonpermissive temperature, glp-
4(bn2ts) mutants produce a somatic gonad that is largely
devoid of germ cells (Beanan and Strome 1992), fem-
2(e2105ts) mutants make oocytes but no sperm, and
fem-3(q20sd) mutants make sperm but no oocytes (Bar-
ton et al. 1987). We detected gla-3 expression in all three
mutant backgrounds, demonstrating that gla-3 is ex-
pressed in both germline and soma (Fig. 3B). Very low
levels of mRNA were observed in gla-3(op212) mutants,
consistent with the finding that this mutation causes a
premature stop, which often results in rapid elimination
of the mutant transcript via nonsense-mediated decay
(Weischenfeldt et al. 2005).
To investigate the expression pattern of GLA-3 in
vivo, we generated strains carrying a GFP reporter driven
by the gla-3 promoter. A 1.5-kb genomic fragment up-
stream of the T02E1.3a ATG was fused to a fragment
coding for nuclear localized GFP, and transgenic animals
were generated by biolistic transformation (Praitis et al.
2001). GFP expression was observed throughout the
germline from the L4 stage onward and in all cells of the
early embryo (Fig. 3C), consistent with the gla-3 mRNA
pattern in the developmental Northern blot (Fig. 3A).
Interestingly, expression was also observed in muscle
cells in threefold stage embryos (Fig. 3C, panel c).
To further investigate temporal and spatial gla-3 ex-
pression, we raised specific polyclonal antibodies against
peptides derived from the unique N termini of GLA-3A
(T02E1.3a) and GLA-3B (T02E1.3b). Western blot analy-
sis of synchronized wild-type worms revealed that both
isoforms are expressed at the L4 and adult stages,
whereas no expression was detectable from the L1 to L3
stages, nor in gla-3(op212) mutants (Fig. 3D). To exam-
ine the expression pattern of GLA-3 in the germline, we
investigated the localization of the GLA-3 protein by in
situ immunostaining. Consistent with the mRNA ex-
pression pattern, GLA-3B was detectable in L4 and adult
gonads. The protein was expressed in the mitotic and
meiotic zones of the adult germline, and localized to the
cytoplasmic compartment, with an enrichment in corti-
cal/submembrane regions (Fig. 3E); a similar pattern of
expression was observed with GLA-3A (data not shown).
The GLA-3B staining was absent in the gonads of gla-
3(op212) mutants (Fig. 3E).
Loss of gla-3 results in impaired oocyte development
gla-3(lf) mutants were morphologically normal, but ex-
hibited a greatly reduced brood size and a low frequency
of embryonic lethality (Table 1). Both defects were
milder in gla-3(op216) mutants, consistent with the pre-
dicted hypomorphic nature of this mutation (which af-
fects only one of the two GLA-3 isoforms). All three
mutants showed a further reduction in brood size when
raised at high temperature (25°C) (Table 1). Because this
reduction was also apparent in the predicted null mutant
gla-3(op212), we surmise that loss of gla-3 function un-
covers an intrinsically temperature-sensitive process
that is required for oocyte development.
What is the cause of the low brood size in gla-3 mu-
tants? Sperm in gla-3(op212) hermaphrodites and males
appeared morphologically normal. We tested the fertility
of gla-3(lf) sperm by mating gla-3(lf) males with unc-
32(e189) hermaphrodites, and found that the mating ef-
ficiency of gla-3(lf) males is comparable to that of wild-
type animals (Supplemental Table I). Our results indi-
Figure 2. GLA-3 encodes a TIS11-like zinc-finger-containing
protein. (A) Schematic representation of gla-3 genomic struc-
ture. T02E1.3 is predicted to have two alternatively spliced
forms, which differ in their first two exons. Black boxes indicate
exons that are common between T02E1.3a and T02E1.3b; the
gray arrow indicates the 3-untranslated part of the last exon.
White boxes represent alternative 5-exons that are not shared
between the two isoforms. Positions of the gla-3(op212), gla-
3(op216), and gla-3(ep312) lesions are indicated. Size bar, 200
bp. (B) Alignment of the two zinc-finger domains of C. elegans
GLA-3, MEX-1, PIE-1, Drosophila melanogaster dTIS11, and
mouse mTIS11. Conserved residues are highlighted in black,
dark gray, or light gray, depending on whether five out of five,
four out of five, or three out of five proteins possess an identical
or similar amino acid at this position. Amino acids that coor-
dinate the zinc atom are marked with asterisks.
Kritikou et al.
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cate that the fertility defects in gla-3(lf) mutants likely
stem from an oogenesis defect.
Consistent with the above conclusion, the gonads of
gla-3(op212) adult hermaphrodites contained few, abnor-
mally shaped oocytes (Fig. 4A). To examine whether the
reduced brood size was the result of excessive apoptosis,
we observed gonads of gla-3(op212); ced-3(n717) double
mutants. Although apoptosis was completely suppressed
in these animals (Figs. 1C, 4A), oogenesis was still im-
paired, indicating that gla-3 function is necessary for oo-
cyte differentiation rather than germ cell survival per se
(Table 1).
To further investigate the oogenesis defect, we stained
germ cell nuclei in wild-type and gla-3(lf) worms with
4,6-diamidino-2-phenylindole dihydrochloride (DAPI).
In wild-type worms, the transition from mitosis to meio-
sis occurs at the middle of the distal arm, and pachytene
nuclei become visible beyond the transition zone. Oo-
cytes then enter diakinesis in the proximal arm of the
gonad, where highly condensed chromosomes can be
seen (Fig. 4B). The distal gonads of gla-3(op212) mutants
were indistinguishable from those of wild-type animals
when observed under Nomarski optics or by DAPI stain-
ing (Fig. 4A,B). However, only few oocytes developed to
the diakinesis stage in the proximal gonads of gla-
3(op212) adults; detailed analysis revealed that this re-
gion was filled mostly with pachytene-stage nuclei (Fig.
4B; data not shown).
Inhibition of apoptosis did not significantly improve
the differentiation defects that are caused by loss of gla-3
function: DAPI staining of gla-3(op212); ced-3(n717)
double mutants revealed an unusually large number of
pachytene-stage nuclei in the proximal arm (Fig. 4; data
not shown). The double mutant did contain more diaki-
Figure 3. gla-3 expression is developmen-
tally regulated. (A) A Northern blot of to-
tal RNA isolated from synchronized wild-
type animals was probed with a gla-3
cDNA as described in Materials and Meth-
ods. -Tubulin was used as a loading con-
trol. (B) gla-3 mRNA is present in both
germline and soma. Poly(A)+ RNA was ex-
tracted from synchronized wild-type, fem-
2(e2105ts) (oocytes only), fem-3(q20sd)
(sperm only), and glp-4(bn2ts) (no germ
cells) adults. -Tubulin was used as a load-
ing control. (C) Pgla-3a2xNLSgfp expres-
sion in C. elegans embryos and germline.
Ubiquitous expression was observed in
early embryos (a,b) and in the germline at
the L4 larval (d) and adult (e) stages. Ex-
pression was also observed in muscle cells
in threefold embryos (c). (D) Western blot
analysis of a developmental time course of
wild-type and adult gla-3(op212) worms
using isoform-specific anti-GLA-3 anti-
bodies. Total protein was extracted as de-
scribed in Materials and Methods. Twenty
micrograms of total protein was loaded per
lane; -tubulin was used as a loading con-
trol. (E) Localization of GLA-3B in adult
hermaphrodite gonads. Gonads were dis-
sected from wild-type and gla-3(op212)
worms 24 h after the L4/adult molt and
were stained with the anti-GLA-3B-spe-
cific antibody 1297 and DAPI. Scale bar in
C and E, 8 µm.
C. elegans GLA-3 controls MAPK signaling
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nesis stage oocytes than the gla-3 single mutant; how-
ever, these diakinetic oocytes were misshapen and ab-
normally small. These results indicate that inhibition of
apoptosis allows more female germ cells to enter diaki-
nesis in gla-3 mutants, but does not rescue the gla-3(lf)
differentiation defect(s).
Biochemical interaction of GLA-3 and MPK-1 in vitro
and in vivo
To identify molecular links between GLA-3 and other
proteins involved in oogenesis, we searched the worm
interactome (WI5, http://vidal.dfci.harvard.edu/interac-
tomedb) for interaction partners of GLA-3, and found a
yeast two-hybrid (Y2H) interaction between GLA-3 and
the two isoforms of MPK-1. Using these two MPK-1 iso-
forms as baits, both GLA-3 isoforms were found as the
predominant preys (over 50% of hits) in the AD-cDNA
and AD-ORFeome prey libraries (Li et al. 2004; data not
shown). MPK-1 is the C. elegans homolog of the mam-
malian ERK1/2 serine/threonine kinases. MPK-1 is re-
quired for germline development: In mpk-1(lf) mutants,
germ cells fail to exit the pachytene stage of meiosis I,
resulting in sterility and decreased germ cell apoptosis
(Church et al. 1995; Lackner and Kim 1998; Gumienny
et al. 1999).
To verify the Y2H result, we performed glutathione-S-
transferase (GST) affinity purification experiments in
293T cells transfected with MPK-1 fused to GST and
myc-tagged GLA-3. Both isoforms of GLA-3 interacted
with both isoforms of MPK-1 (Fig. 5A). To validate the in
vitro evidence and show that MPK-1 interacts with
GLA-3 in vivo, we immunoprecipitated GLA-3 from C.
elegans extracts and tested for MPK-1 binding. As illus-
trated in Figure 5B, MPK-1 could be immunoprecipitated
with both isoforms of GLA-3. Our findings show a direct
interaction between GLA-3 and MPK-1 in vitro and in
vivo, and provide a possible explanation for the germline
defects observed in gla-3(lf) mutants.
To define the GLA-3 binding interface on MPK-1, we
used the reverse Y2H system. We screened a PCR-muta-
genized library of mpk-1 and selected for mutants that
could no longer interact with GLA-3. From this set of
mutants, we analyzed further those with a single, non-
silent nucleotide change. In total, we identified 20
unique amino acid substitutions that represent 17 differ-
ent amino acid positions on MPK-1 (Table 2). The ma-
jority (nine out of 17) of the amino acid changes that lead
to a disruption of the interaction between MPK-1 and
GLA-3 clustered to a small region on the surface of
MPK-1 (Fig. 6). The region defined by these residues is
structurally conserved between MPK-1 and ERK2 and
Figure 4. Loss of gla-3 function results in
meiotic arrest during oogenesis. (A) Wild-
type, gla-3(op212), and gla-3(op212); ced-
3(n717) adult hermaphrodite animals were
examined using DIC microscopy. In wild-
type worms, oocytes enter diakinesis in
the proximal arm of the gonad (arrow). Ar-
rowheads indicate apoptotic corpses in
gla-3(lf) animals. (B) Images of DAPI-
stained gonads from wild-type, gla-
3(op212), and gla-3(op212); ced-3(n717)
adult hermaphrodites. Pachytene nuclei
are evident around the bend of the gonad
arm. The proximal arm of gla-3(op212)
mutants contained an excess of pachytene
nuclei compared to wild-type worms. The
asterisk indicates the first diakinetic
nucleus in the proximal arm of gla-3(lf);
ced-3(lf). Scale bar, 8 µm.
Table 1. gla-3(lf) mutants have a reduced brood size and suffer from embryonic lethality
Genotype
Brood size Survival (%)
20°C (n = 17) 25°C (n = 15) 20°C (n = 20) 25°C (n = 15)
Wild type 259 ± 18 264 ± 23 98 ± 2 99 ± 5
ced-3(n717) 263 ± 22 280 ± 18 98 ± 5 96 ± 6
gla-3(op212) 20 ± 3 5.7 ± 2.1 81 ± 7 75 ± 3
gla-3(ep312) 12 ± 5 4.8 ± 1.4 76 ± 8 72 ± 9
gla-3(op216) 180 ± 25 112 ± 45 95 ± 6 90 ± 4
gla-3(op212); ced-3(n717) 14 ± 3 11 ± 2 85 ± 3 81 ± 5
gla-3(ep312); ced-3(n717) 13 ± 5 10 ± 3 75 ± 10 79 ± 6
gla-3(op216); ced-3(n717) 100 ± 20 53 ± 31 90 ± 8 91 ± 5
Brood size and survival rate were scored as previously described (Hofmann et al. 2002). The data shown are the average ± SD. (n)
Number of broods analyzed.
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has been shown to function as a docking site for both
regulators and targets of MAPK, such as the phosphatase
MKP3 and the kinase ELK1 (Table 2; Zhang et al. 2003).
In addition, GLA-3 contains potential MPK-1 binding
sites, as defined by a cluster of positive amino acids sur-
rounded by hydrophobic amino acids (Tanoue and
Nishida 2002). GLA-3a has one site at position 66–74
(LRKVVRIDR), whereas GLA-3b has two such sites, at
positions 66–74 (LRKTKI) and 99–107 (LRKVVRIDE).
Taken together, our biochemical and molecular data are
consistent with a role of GLA-3 as a regulator or a target
of MPK-1 in the C. elegans germline.
gla-3 genetically interacts with components of the
MAPK signaling pathway
Do ras/MAPK pathway genes regulate the apoptotic pro-
gram? Strong loss-of-function mutations in the mpk-1
pathway cause a sterile phenotype due to developmental
arrest at the pachytene stage of meiosis (Church et al.
1995). We and others have previously shown that pachy-
tene-arrested cells do not undergo apoptosis (Gumienny
et al. 1999; Navarro et al. 2001). To address the role of
mpk-1 in gla-3(lf)-induced cell death, we performed ge-
netic epistasis analysis between gla-3 and genes that are
known to be involved in the Ras/MAPK pathway. Using
the putative null mutation mpk-1(ga117) (Lackner and
Kim 1998), we found that gla-3(op212)-induced apopto-
sis was completely abrogated in gla-3(op212); mpk-
1(ga117) double mutants (Fig. 7A). Interestingly, al-
though apoptosis is suppressed, gla-3 does not rescue the
sterile phenotype of mpk-1(ga117) (Supplemental Table
II). These data demonstrate that mpk-1 is epistatic to
gla-3, and that its activation is required for gla-3(lf)-in-
duced germ cell death. We then compared the levels of
germ cell death in mpk-1(oz140) ced-9(n2812) adult her-
maphrodites with those in gla-3(RNAi); mpk-1(oz140)
ced-9(n2812) animals. ced-9(lf)-induced and gla-
3(RNAi)-induced germ cell apoptosis were both com-
pletely suppressed in the absence of functional mpk-1
(Gumienny et al. 1999; Supplemental Table III).
We also analyzed the effect on germline apoptosis of
mutants that cause overactivation of MPK-1. We ob-
served no increase in germ cell apoptosis in the ras gain-
of-function mutant let-60(ga89). Similarly, gla-3(op212);
let-60(ga89) double mutants had levels of apoptosis that
were comparable to gla-3(op212) alone (Fig. 7B). In con-
trast, inactivation of LIP-1, an MPK-1 phosphatase that
functions as a negative regulator of MAPK signaling
(Hajnal and Berset 2002), resulted in increased germline
apoptosis, with levels comparable to gla-3 mutants (Fig.
7B). Similarly to gla-3 mutants, lip-1(zh15)-induced
germline apoptosis depended on ced-3 but was cep-1-
independent (Supplemental Fig. 3), indicating that these
two genes might function in the same genetic pathway.
Indeed, gla-3(op212); lip-1(zh15) double mutants showed
only a slight increase in germline apoptosis over the
single mutants (Fig. 7B).
lip-1(zh15) mutants display accelerated oocyte devel-
Table 2. Point mutations in MPK-1 that disrupt interaction
with GLA-3
Positiona Hits Wild type Mutant DSc
130 1 Ser (TCT) Pro (CCT) No
131 1 Ser (TCT) Phe (TTT) No
253 14 Asn (AAT) Asp (GAT) Yes
391 1 Tyrb (TAC) His (CAC) Yes
391 1 Tyrb (TAC) Asp (GAC) Yes
398 3 Leu (CTC) Pro (CCC) Yes
410 1 Leu (CTC) Pro (CCC) Yes
413 1 Argb (CGT) His (CAT) Yes
433 1 Ser (TCT) Pro (CCT) No
473 1 Leu (TTG) Ser (TCG) No
479 1 Leu (CTC) Pro (CCC) Yes
490 1 Cys (TGT) Ser (AGT) Yes
491 1 Cys (TGT) Tyr (TAT) Yes
497 1 Leu (CTC) Pro (CCC) Yes
653 1 Gly (GGA) Glu (GAA) No
655 1 Cys (TGT) Arg (CGT) No
692 1 Phe (TTC) Ser (TCT) No
719 1 Leu (CTC) Pro (CCC) No
896 1 Phe (TTC) Ser (TCC) No
955 1 Tyrb (TAC) His (CAC) Yes
aPosition indicates nucleotide position based on MPK-1 isoform a.
bResidues necessary for docking that are identical in MPK-1 and
ERK2.
cAmino acids that are part of the predicted MPK-1 docking site.
Figure 5. MPK-1 and GLA-3 interact in vitro and in vivo. (A)
Myc-GLA-3 and GST-MPK-1 interact in 293T cells. 293T cells
were transfected with plasmids expressing Myc-tagged GLA-3A
or GLA-3B isoforms and GST-MPK-1A or GST-MPK-1B. GST-
MPK-1A or GST-MPK-1B was affinity-purified using glutathi-
one beads, and the presence of Myc-GLA-3A or Myc-GLA-3B
was detected by immunoblotting using an anti-Myc antibody.
(B) MPK-1 interacts with GLA-3 in C. elegans. Total protein
was extracted from synchronized adult hermaphrodites, and im-
munoprecipitation was performed using anti-GLA-3A or GLA-
3B antibodies. Pre-immune serum was used as a control. Immu-
noprecipitated samples were probed with an antibody against
mammalian ERK1/2, which recognizes C. elegans MPK-1 (top
panel) (Lackner and Kim 1998) and with antibodies against
GLA-3A or GLA-3B (bottom panel).
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opment due to defective G2/M-phase arrest (Hajnal and
Berset 2002). We scored the number of diakinetic oocytes
in the gonads of single and gla-3(op212); lip-1(zh15)
double mutants and found that the double mutants ex-
hibited decreased numbers of diakinetic oocytes, a phe-
notype similar to gla-3(op212) single mutants (Supple-
mental Table II). These observations suggest that gla-3 is
epistatic to lip-1 for germ cell differentiation.
gla-3 mutations do not result in MPK-1 overactivation
To test whether loss of gla-3 function altered the pattern
of MPK-1 activation in the germline, we stained dis-
sected gonads with a monoclonal antibody that specifi-
cally recognizes the diphosphorylated, activated form of
MPK-1 (DP-MPK-1). As previously reported (Miller et al.
2001; Page et al. 2001), MPK-1 was activated in pachy-
tene-stage cells and also, in response to the sperm signal,
in the first and sometimes second oocyte proximal to the
spermatheca (Supplemental Fig. 4A). The pattern of
MPK-1 activation in gla-3(op212) mutants was similar to
that of wild-type animals, although the DP-MPK-1 stain-
ing in the oocytes proximal to the spermatheca was oc-
casionally weaker (Supplemental Fig. 4A), possibly re-
flecting the abnormal nature of oocytes in gla-3 mutants.
To further test the hypothesis that GLA-3 might regu-
late the levels of activated MPK-1, we used an in vitro
MPK-1 kinase assay (Alessi et al. 1995; Berset et al.
2001). Using myelin basic protein (MBP) as an MAPK
substrate, we found that both lip-1(zh15) and let-
60(n1046gf) animals had higher levels of MAPK enzy-
matic activity when compared with the wild type
(Supplemental Fig. 4B). In contrast, the level of MAPK
activity in gla-3(op212) and gla-3(op216) mutants was
similar to the wild type (Supplemental Fig. 4B). Taken
together, these data indicate that inactivation of GLA-3
does not directly affect the activation of MPK-1 protein
itself.
GLA-3 is a negative regulator of the MAPK signaling
pathway in somatic tissues
During C. elegans development, LET-60/Ras and MPK-
1/MAPK transmit the LIN-3/EGF inductive signal in
Figure 6. Identification of MPK-1 residues required for the in-
teraction with GLA-3. The reverse two-hybrid system was used
to identify residues that are essential for the MPK-1/GLA-3 in-
teraction. Residues, which when altered result in disruption of
the interaction, are shown in black in the space-filling model
(top panels) and in yellow in the ribbon model (bottom panels)
of MPK-1. Residues with visible surface exposure are noted on
the structure, and those that are identical between MPK-1 and
its mammalian homolog ERK2 are noted with an asterisk. Left
and right panels represent a 90° rotation of the structure on its
axis.
Figure 7. Genetic interactions between gla-3 and genes in-
volved in Ras/MAPK signaling. (A) unc-32(e189), gla-3(op212);
unc-32(e189), unc-32(e189) mpk-1(ga117), and gla-3(op212);
unc-32(e189) mpk-1(ga117) animals were synchronized, and
germ cell corpses were counted over 48 h starting at the L4
stage. (B) Synchronized gla-3(op212), let-60(ga89), lip-1(zh15),
gla-3(op212); let-60(ga89), and gla-3(op212); lip-1(zh15) animals
were raised at 25°C, and germline corpses were counted starting
at the L4 stage. Error bars represent SD from three independent
experiments; 20 gonads were scored in each experiment.
Kritikou et al.
2286 GENES & DEVELOPMENT
 on October 11, 2006 www.genesdev.orgDownloaded from 
vulval precursor cells (VPCs), resulting in vulva forma-
tion (Moghal and Sternberg 2003). Loss-of-function mu-
tations in genes that mediate the inductive signaling
pathway can lead to a vulvaless (Vul) phenotype due to
insufficient induction of VPCs. Conversely, mutations
that enhance the inductive signal result in a multivulva
(Muv) phenotype, due to hyperinduction of VPCs.
To test the possibility that GLA-3 might also influ-
ence MAPK signaling during vulval development, we ex-
amined double mutants between gla-3(lf) and various
mutations that affect vulval induction. In gla-3(lf) single
mutants, vulval development appeared normal (Table 3).
However, loss of gla-3 function enhanced the multivulva
phenotype observed in two different let-60(gf) mutants
(Table 3), suggesting that GLA-3 might function as an
inhibitor of MAPK signaling in VPCs. Similarly, vulval
development is normal in lip-1(lf) mutants (Berset et al.
2001), whereas double gla-3(op212); lip-1(zh15) mutants
displayed a weak synthetic Muv phenotype (Table 3). In
contrast, the gla-3 alleles could not suppress the mpk-
1(ga117) vulvaless phenotype. Taken together, these re-
sults indicate that GLA-3 might function as an inhibitor
of MAPK signaling during vulval development.
Activation of the Ras/MAPK pathway has also been
shown to promote protein degradation in C. elegans
muscles, leading to a progressive loss of motility (Szew-
czyk et al. 2002). We therefore investigated whether
gla-3 might influence muscle-protein degradation
through its interaction with the Ras/MAPK pathway.
Whereas gla-3 mutants raised at 15°C showed nearly
wild-type movement, animals shifted to 25°C at the L4
stage suffered a progressive loss of motility, similar to
the defect observed in let-60(ga89) mutants (Table 4).
The locomotion defect was not significantly enhanced in
the gla-3(lf); let-60(lf) double mutants, implying that the
two genes might affect the same molecular process.
We then monitored protein degradation using an unc-
54LacZ transgene that is expressed specifically in body
wall and vulval muscles (Zdinak et al. 1997; Szewczyk et
al. 2000). This fusion protein is completely stable in
well-fed wild-type worms; therefore, any subsequent de-
cline in LacZ activity is the result of protein degradation.
Well-fed gla-3(op212) mutants exhibited wild-type levels
of LacZ activity when grown at 15°C. In contrast, mu-
tants shifted to 25°C at the L4 stage showed a time-
dependent loss of reporter activity similar to the loss
observed in mutants with an overactivated Ras/MAPK
pathway (Fig. 8). Taken together, these observations in-
dicate that GLA-3 might negatively regulate Ras/MAPK-
dependent protein degradation in muscle cells.
Discussion
Although much is known about the core apoptotic ma-
chinery and the signals that regulate apoptosis during C.
elegans development (for review, see Lettre and Hengart-
ner 2006), the factors that regulate germline apoptosis
are largely unknown. In an attempt to isolate such regu-
Table 3. gla-3 is a negative regulator of vulva induction
Genotype
%
Muv
Average
P(3–8).p
vulval fates
Number
of animals
Wild type 0 3.0 75
gla-3(op212) 0 3.0 69
gla-3(op216) 0 3.0 74
let-60(n1046sd) 80 4.0 54
let-60(ga89) 42 3.5 64
lip-1(zh15) 0 3.0 60
unc-32(e189) 0 3.0 45
unc-32(e189) mpk-1(ga117) 0 0 54
gla-3(op212); let-60(n1046) 97 4.9 48
gla-3(op216); let-60(n1046) 91 5.1 52
gla-3(op212); let-60(ga89) 66 4.5 68
gla-3(op216); let-60(ga89) 63 4.4 84
gla-3(op212); lip-1(zh15) 4.5 3.3 66
gla-3(op216); lip-1(zh15) 3.8 3.1 71
gla-3(op212); unc32(e189)
mpk-1(ga117) 0 0 65
gla-3(op216); unc-32(e189)
mpk-1(ga117) 0 0 58
Table 4. gla-3(lf) causes time-dependent loss of mobility
Movement rate (waves/min)
Genotype Temp (°C) 0 24 48 72
Wild type 15 98 ± 14 96 ± 12 108 ± 8 103 ± 5
gla-3(op212) 15 → 25 99 ± 8 110 ± 17 102 ± 9
15 100 ± 8 97 ± 15 93 ± 19 109 ± 8
15 → 25 78 ± 16 61 ± 10 57 ± 12
gla-3(op216) 15 109 ± 11 103 ± 8 97 ± 5 102 ± 8
15 → 25 82 ± 7 63 ± 11 60 ± 7
let-60(ga89) 15 100 ± 14 95 ± 15 98 ± 2 101 ± 14
15 → 25 83 ± 9 56 ± 15 54 ± 10
gla-3(op212); let-60(ga89) 15 90 ± 9 99 ± 11 97 ± 9 89 ± 12
15 → 25 71 ± 5 54 ± 7 48 ± 11
gla-3(op216); let-60(ga89) 15 96 ± 13 100 ± 7 106 ± 4 94 ± 6
15 → 25 76 ± 13 62 ± 7 61 ± 4
Data shown are average ± SD from two independent experiments; 15 animals were scored per experiment.
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lators, we performed a genetic screen and identified gla-
3. We found that gla-3 is important for oocyte differen-
tiation and germ cell survival and encodes a TIS11-like
zinc-finger-containing protein. We showed that GLA-3
genetically and physically interacts with the C. elegans
MAPK MPK-1 and provided evidence to support the no-
tion that GLA-3 might function as a negative regulator of
the MAPK pathway in the developing vulva and in
muscle cells.
Regulation of germline apoptosis by GLA-3 and other
RNA-binding proteins
We showed that gla-3 has two isoforms, which differ in
their two 5-most exons. Are both isoforms involved in
germline apoptosis and oocyte development? Both GLA-
3A and GLA-3B are expressed in the germline, and both
isoforms interact with MPK-1. Furthermore, the op216
mutation, which is predicted to affect only GLA-3A,
shows weaker defects than the predicted null alleles.
Based on these results, we suggest that both isoforms
might participate in germline development and apopto-
sis. However, further work is required to confirm this
hypothesis, and to determine whether the isoform-spe-
cific N-terminal domains perform distinct functions.
How could GLA-3 regulate germ cell apoptosis? The
TIS11-like proteins that have previously been character-
ized in C. elegans, including PIE-1, POS-1 MEX-1, MEX-
5, and MEX-6, function in a hierarchical regulatory cas-
cade that controls cell fate during early embryonic de-
velopment (Schneider and Bowerman 2003). In addition,
the combined loss of the TIS11-like proteins, OMA-1
and OMA-2, results in impaired oocyte maturation and
female infertility (Detwiler et al. 2001). The mammalian
TIS11 zinc-finger-containing protein, tristetraprolin
(TTP), is an RNA-binding protein that interacts with 3-
untranslated AU-rich elements of mRNAs and nega-
tively regulates their expression (Lai et al. 1999; Carballo
et al. 2000; Cao et al. 2003). Based on the homology be-
tween the C. elegans and the mammalian TIS11-like
proteins, it is possible that PIE-1, POS-1, MEX-1, MEX-5,
MEX-6, and GLA-3 exert their functions by acting as
mRNA-binding proteins (Barabino et al. 1997; Lai et al.
2000; Worthington et al. 2002).
Inactivation of several RNA-binding proteins, includ-
ing DAZ-1, CGH-1, CPB-3, and CAR-1, has previously
been shown to trigger apoptosis in the C. elegans germ-
line (Karashima et al. 2000; Navarro et al. 2001; Lettre et
al. 2004; Boag et al. 2005). Similarly to gla-3, daz-1 mu-
tations result in severe oogenic defects due to arrest at
the pachytene stage of meiosis I. It is possible that these
genes coordinately regulate the synthesis of pro-apopto-
tic or survival proteins during germline development.
Indeed, CGH-1 and CAR-1 interact physically and are
components of an evolutionarily conserved RNP com-
plex (Boag et al. 2005). Alternatively, these proteins
might function more broadly to promote germline differ-
entiation, and the developmental defects that result
from their loss could be the cause of the apoptotic phe-
notypes observed. Identification of the target mRNAs
regulated by these various proteins is required to shed
light on this issue.
GLA-3 is a novel component of the MAPK signaling
cascade
In addition to its potential function as an RNA-binding
protein, GLA-3 also interacts physically with the C. el-
egans MAPK MPK-1 in vitro and in vivo, indicating that
GLA-3 might have a role in MPK-1 signaling. In the her-
maphrodite germline, activation of the LET-60/MEK-2/
MPK-1 signaling pathway is essential for pachytene pro-
gression and subsequent entry into diplotene/diakinesis
(Church et al. 1995; Lackner and Kim 1998; Miller et al.
2001; Page et al. 2001). Although MPK-1 activation dur-
ing pachytene progression appears to be transient and
tightly regulated (Hajnal and Berset 2002), the nature of
the signal that controls its activation and the down-
stream effectors of MPK-1 remain poorly characterized.
Based on its mutant phenotype and its physical interac-
tion with MPK-1, GLA-3 might be directly involved in
this process.
Because our expression studies revealed that GLA-3
expression is not restricted to the germline, we also stud-
ied the potential role of GLA-3 in MPK-1 signaling in the
soma. We found that the absence of gla-3 resulted in
phenotypes consistent with an inappropriate activation
of mpk-1 signaling in both vulval development and pro-
tein degradation in body wall muscles. These biochemi-
cal and genetic analyses support the idea that GLA-3
functions as a negative component of the Ras/MAPK
pathway. However, we were so far unable to detect any
change in MPK-1 activity in gla-3 mutants or worm ex-
tracts (Supplemental Fig. 4), suggesting that GLA-3 does
not directly regulate MPK-1 activation but, rather, might
restrict its access to or interaction with substrates.
Could GLA-3 be a substrate rather than—or in addi-
tion to—a regulator of MPK-1? Neither our genetic nor
our biochemical data allow us to definitively exclude
this possibility. We did not observe any differences in the
Figure 8. gla-3(lf) promotes proteolysis in body wall muscles.
Animals were raised at 15°C until the young adult stage (left
panel), and then shifted to 25°C for 48 or 72 h (right panels).
-Galactosidase activity (blue) was measured as described in
Materials and Methods. Scale bar, 0.2 mm.
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GLA-3 protein levels in different mutants of the MAPK
pathway by Western blot analysis and in situ immuno-
staining (Supplemental Fig. 5; data not shown), which
indicated that MPK-1 does not directly regulate GLA-3
levels. However, it is possible that MPK-1 phosphory-
lates GLA-3 and this modification is important for
GLA-3 function. Indeed, several kinases, including
MAPKMAP kinase 2 (MK2), ERK2, p38, and JNK, can
phosphorylate the mammalian TIS11 protein tristetrap-
rolin in response to growth factor or cytokine treatment
(Taylor et al. 1995; Mahtani et al. 2001; Chrestensen
et al. 2004). Although GLA-3 has several potential
MAPK phosphorylation sites, we were unable to deter-
mine whether GLA-3 is phosphorylated by MPK-1 in
vivo using the antibody that we raised (Supplemental
Material 5).
What is the function of GLA-3 in the MAPK signaling
pathway?
In Schizosaccharomyces pombe, MAPK signaling activ-
ity can be regulated through a negative feedback loop
that involves Rnc1, a KH-domain-containing RNA-bind-
ing protein that stabilizes the Pmp1 phosphatase mRNA
(Sugiura et al. 2003). Based on the ability of GLA-3 to
bind to MPK-1 and its predicted RNA-binding domains,
a similar model could be envisaged in which GLA-3 is
activated through interaction with MPK-1, and in re-
sponse stabilizes mRNAs encoding negative regulators
of MPK-1 such as LIP-1.
Materials and methods
Strains, alleles, and genetic analysis
Maintenance and genetic manipulation of C. elegans were car-
ried out as described (Brenner 1974). The following mutations
and transgenes were used: LG I: hus-1(op244), gla-3(op212),
gla-3(op216), gla-3(ep312), cep-1(gk138), glp-4(bn2ts); LG II:
lip-1(zh15); LG III: fem-2(e2105ts), mpk-1(ga117), mpk-
1(oz140), ced-4(n1162), clk-2(mn159ts), unc-32(e189), ced-
9(n2812), unc-119(ed3), opIs64[Pgla-3a2xNLSgfp unc-119(+)];
LG IV: fem-3(q20sd), ced-3(n717), let-60(n1046gf), let-
60(ga89gf), opIs110[Plim-7yfpact-5 unc-119(+)]; LG V:
ccIs55[unc-54lacZ; sup-7(st5)], gaIs36[HS-mpk-1(+) EF1-D-
mek(+) unc-30(+)]. All mutations are described in WormBase
(http://www.wormbase.org). The Bristol strain N2 was used as
the wild-type strain. Strains were maintained at 20°C unless
stated otherwise. Unless specified otherwise, all phenotypic
characterizations were performed on hermaphrodites 24 h post-
L4/adult molt. Movement rates were measured as described (Bo-
lanowski et al. 1981).
Isolation of gla-3 alleles
gla-3(lf) alleles were isolated in an F2 screen for mutants with
increased germ cell apoptosis. Wild-type animals were muta-
genized with ethylmethane sulfonate using a standard protocol
(Brenner 1974), and adult F2 animals with increased apoptotic
germ cell corpses were identified with the vital dye acridine
orange (AO; Sigma) (Lettre et al. 2004). Two independent alleles
(op212 and op216) were isolated from a screen of 45,000 ge-
nomes. To eliminate possible additional mutations, each mu-
tant was crossed back to the wild type eight times before sub-
sequent analysis. The ep312 deletion allele was isolated in a
separate screen, performed to identify mutants involved in cep-
1-independent germ cell apoptosis (M. Costa, pers. comm.).
Cloning of gla-3
The op212 allele of gla-3 was mapped near the middle of Chro-
mosome I by two-factor mapping using the marker dpy-5. To
refine the position of gla-3, three-factor mapping was conducted
using the following marker combinations: dpy-5 unc-87, dpy-5
unc-29, and dpy-24 unc-75. This analysis placed gla-3 closer to
unc-29 than dpy-5. SNP mapping refined the region to 0.36 cM
(roughly 270 kb), which included 40 predicted genes. We then
performed RNAi feeding of the 40 genes in this interval. Only
inactivation of T02E1.3 resulted in increased germline apopto-
sis. The molecular changes induced by the op212, op216, and
ep312 mutations were determined by PCR amplification of the
gla-3 locus from the respective mutants, followed by sequenc-
ing of both strands of the amplification product.
RNA interference
Feeding RNAi was performed as previously described (Lettre et
al. 2004). Feeding RNAi constructs were obtained either from
the Ahringer library (Kamath et al. 2003) or from the ORFeome
RNAi collection (Rual et al. 2004), or were generated by sub-
cloning from cDNAs (for bir-1 and gfp).
Germline apoptosis
Apoptotic germ cell corpses were identified and quantitated
based on their characteristic morphology under differential in-
terference contrast (DIC) optics, as previously described (Gumi-
enny et al. 1999).
Brood size and oocyte counts
Brood size counts were performed as previously described (Hof-
mann et al. 2002). Oocyte counts were performed according to
Hajnal and Berset (2002).
Northern analysis
Total RNA was isolated using TRIZOL reagent (GIBCO-BRL)
from cultures of synchronized wild-type worms at different de-
velopmental stages as well as from gla-3(op212), glp-4(bn2ts),
fem-2(e2105ts), and fem-3(q20sd) adults. Poly(A)+ selection of
mRNAs from staged adults was performed using the Micro-
PolyA kit (Ambion). RNA samples were subjected to formalde-
hyde agarose gel electrophoresis, transferred to Hybond N+ ny-
lon membrane, and probed with a full-length gla-3 cDNA am-
plified from plasmid yk6h11 and labeled with 32P using the
random hexamer primer method.
Generation of GLA-3 antibodies
Rabbit polyclonal antibody T02E1.3a (1301) was raised against
the T02E1.3a peptide KTQEISVVIDPRDA, whereas antibody
T02E1.3b (1297) was raised against the T02E1.3b peptide LLNS-
DMDPVRNLES. Peptides were synthesized (Sigma-Genosys)
and injected into two rabbits according to Sigma protocols.
Western blot analysis
Adult worms were washed off the plates with water. Worm
pellets were frozen in liquid nitrogen and kept at −80°C. To
C. elegans GLA-3 controls MAPK signaling
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extract proteins, an equal volume of acid-washed glass beads
(Sigma) was added to the frozen worm pellet, and the tubes were
put in a bead beater (FastPrep FP120) for 35 sec at speed 6.5.
Following addition of 100–300 µL of RIPA buffer (50 mM Tris at
pH 8.0, 150 mM NaCl, 1% NP-40, 1% deoxycholate, 1% SDS,
1 tablet/10 mL Complete Mini protease inhibitor [Roche]) or
immunoprecipitation buffer (25 mM HEPES-NaOH at pH 7.4,
150 mM NaCl, 0.2 mM DTT, 10% glycerol, 1% Triton X-100, 1
tablet/10 mL Complete Mini protease inhibitor [(Roche]), tubes
were vortexed and incubated on ice for 10 min. Extracts were
centrifuged for 15 min at 13,000 rpm at 4°C. Supernatants were
collected and kept at −80°C. Protein quantification was done
using the Bio-Rad protein assay as recommended, with bovine
serum albumin (BSA) as standard. The antibody dilutions used
were 1:1000 for GLA-3 antibodies and 1:10,000 for -tubulin
(Upstate). Secondary HRP-labeled anti-rabbit and anti-mouse
antibodies (Sigma) were used at 1:100,000 and 1:40,000, respec-
tively, and detected using ECL (Sigma).
Transgenic worms
The Pgla-3a2xNLSGFP unc-119(+) construct (pEK1) was bom-
barded into unc-119(ed3) worms as previously described (Praitis
et al. 2001; Hofmann et al. 2002). Integration of each construct
was determined by loss of visible Unc-119 offspring. At least
three integrated lines were generated; all showed the same ex-
pression pattern.
Reverse two-hybrid selection
The system we used is a variation of the original reverse two-
hybrid protocol developed by Vidal (Vidal et al. 1996a,b). Briefly,
the mpk-1 wild-type ORF was mutagenized by PCR using 30
amplification cycles and Platinum Taq DNA polymerase (Invit-
rogen). To build the mpk-1 mutant library, the gel-purified PCR
product was cloned into the pDONR-Express vector using the
Gateway in vitro cloning system (Invitrogen). In this vector, the
ORF is cloned under control of an IPTG-inducible promoter in
frame with the KanR gene. Clones containing PCR-induced
STOP mutations are removed by plating TOP-10 (Invitrogen)
bacteria transformants on IPTG (1 mM) and Kan (80 µg/mL)
selective medium. About 500,000 independent transformants
were obtained. The ORFs were LR cloned into the pPC-97 Gal-4
DNA-binding domain yeast two-hybrid vector and retrans-
formed into electrocompetent TOP-10 cells. This library was
transformed into MaV203 yeast cells containing GLA-3 fused to
the Gal-4 activation domain. Cotransformed cells were selected
for their ability to grow on −Leu, −Trp, +5-FOA (5-fluoro-orotic
acid) medium, and the mpk-1 ORF was amplified by PCR and
sequenced so that the causative mutation could be identified.
These mpk-1 mutants were retested by gap repair in fresh
MaV203 containing the AD GLA-3 fusion, to confirm that the
interaction had been disrupted because of the mutation (Wal-
hout and Vidal 2001).
Visualization of amino acid changes on MPK-1
Mutations identified in mpk-1 using the yeast reverse two-hy-
brid system were mapped to the structure model of MPK-1
(SWISS-PROT P39745), which was derived from the rat ERK2
(SWISS-PROT P63086) crystal structure (Zhang et al. 1993,
1994). The location of the changed amino acids was visualized
on the 3D structure using Swiss-PdbViewer (Guex and Peitsch
1997).
GST pull-downs
mpk-1a or mpk-1b ORFs were cloned into pDEST-27, which
contains GST coding sequence upstream of the Gateway recom-
bination site (Invitrogen). gla-3a and gla-3b ORFs were cloned
into pDEST-CMV-myc, which contains the myc tag upstream
of the Gateway recombination site (Invitrogen). Both vectors
use the CMV promoter to drive expression of the fusion protein.
Plasmids were transfected into 293T cells using Lipofectamin
2000 reagent according to the manufacturer’s instructions (In-
vitrogen). Cells were cultured for 2 d in DMEM medium, and
lysed in 0.1% NP-40 buffer (50 mM Tris-HCl at pH 7.5, 150 mM
NaCl, 1 mM EDTA, and complete protease inhibitors [Amer-
sham]). Lysates were centrifuged at 14,000g, before purification
of protein complexes using glutathione Sepharose beads. Puri-
fied complexes and control lysate samples were run on Nu-
PAGE acrylamide gels (Invitrogen), and Myc- and GST-tagged
proteins were detected using standard immunoblotting tech-
niques. Mouse monoclonal anti-Myc (clone 9E10) and rabbit
polyclonal anti-GST were purchased from Sigma.
Immunofluorescence and imaging
Immunostaining was performed essentially as described (Page et
al. 2001). Briefly, dissected gonads were fixed in 1% paraform-
aldehyde in PBS and permeabilized in TBS supplemented with
0.1% Triton X-100. The samples were subsequently incubated
with the following antibodies: rabbit anti-GLA-3A 1301, 1:1000
or rabbit anti-GLA-3B 1297, 1:1000 in 5% BSA in TBS, at 4°C
overnight. Anti-rabbit AlexaFluor 594 or anti-mouse Alexa-
Fluor 594 IgG antibodies were used as secondary antibodies
(Molecular Probes). DAPI was added to a final concentration of
200 ng/mL, and samples were mounted for microscopy. All im-
ages were analyzed by light microscopy with a Zeiss Axioskop
equipped with epifluorescence and differential interference con-
trast (DIC) optics. Digital images were acquired and processed
using a CCD camera and Openlab software. Histochemical
staining of -galactosidase with 5-bromo-4-chloro-3-indolyl--
D-galactopyranoside (X-Gal) was performed as described (Zdi-
nak et al. 1997).
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